Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1429 (LINC01429) is a human long non-coding RNA classified as a long intergenic non-coding RNA (lincRNA), which means it is a transcribed RNA molecule longer than 200 nucleotides and does not overlap any protein-coding gene. Like other lincRNAs, it is presumed to play roles in regulation of gene expression, chromatin structure, and possibly other nuclear processes, though as of the latest available sources, no specific biological function, disease association, or drug targeting information is established for LINC01429 specifically. There is currently no evidence in available search results that LINC01429 functions as a therapeutic target (such as a receptor, enzyme, or transporter), or that it serves as a confirmed disease biomarker or drug target. Its precise biological roles, disease involvement, and clinical relevance remain to be characterized in scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1429 (LINC01429).